Benzinga | Aug 19, 2021 11:47AM EDT

Regeneron Granted FDA Orphan Drug Designation For 'Treatment of stage IA2 to stage IV cervical cancer'

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=671518